Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin LymphomaRobert Chen, Alex F Herrera, Jessie Hou, et al.Haematologica|June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patientsIbrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell TherapyKyuwan Lee, Aleksi Iukuridze, Tianhui He, et al.The Lancet. Haematology|November 20, 2022
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trialAlex F Herrera, Lu Chen, Yago Nieto, et al.Transplantation and Cellular Therapy|July 10, 2026
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantationTamer Othman, Dongyun Yang, Geoffrey Shouse, et al.Clinical Lymphoma, Myeloma & Leukemia|June 4, 2019
Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase MutationsAmandeep Salhotra, Michelle Afkhami, Dongyun Yang, et al.Blood Advances|February 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysisJoseph M Tuscano, Tamer Othman, Paul Frankel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 20, 2019
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single CenterAmandeep Salhotra, Susanta Hui, Dongyun Yang, et al.British Journal of Haematology|April 22, 2020
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphomaSairah Ahmed, Nilanjan Ghosh, Kwang W Ahn, et al.American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.Pageof 8